Low Dose Valganciclovir for CMV Prophylaxis in the First Year of Kidney Transplantation

被引：0
|
作者：
Klem, P. [1 ]
Al-Omar, L. [2 ]
Cooper, J. [2 ]
Davis, S. [2 ]
Gralla, J. [2 ]
Choe, D. [1 ]
Wiseman, A. [2 ]
机构：
[1] Univ Colorado, Pharm, Aurora, CO USA
[2] Univ Colorado, Nephrol, Aurora, CO USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A174
引用
收藏
页码：468 / 468
页数：1
相关论文
共 50 条
  • [1] Low dose valganciclovir for CMV prophylaxis after lung transplantation
    Khurana, H. S.
    Chaux, G.
    Kole, A.
    Falk, J.
    Simsir, S.
    Cheng, W.
    Kass, R. M.
    Khurana, J.
    Soohoo, G.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S72 - S72
  • [2] Efficacy of Low Dose Valganciclovir Prophylaxis for Cytomegalovirus Infection in Kidney Transplantation
    Ozcelik, Umit
    Alpay, Nadir
    Eren, Eryigit
    Uslu, Bora
    Yardimci, Ahmet Cem
    [J]. HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2020, 58 (01): : 27 - 32
  • [3] Universal Prophylaxis with Oral Valganciclovir Significantly Reduces First Year CMV Disease in Kidney Transplant Recipients
    Wu, M. -J.
    Tu, P. -T.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 531 - 531
  • [4] Low-dose valganciclovir is efficacious and safe for prophylaxis of cytomegalovirus infection in kidney transplantation
    Perrottet, Nancy
    Manuel, Oriol
    Venetz, Jean-Pierre
    Lamoth, Frederic
    Decosterd, Laurent A.
    Buclin, Thierry
    Biollaz, Jerome
    Meylan, Pascal
    Pascual, Manuel
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 565 - 566
  • [5] Incidence of CMV Viremia in Obese and Morbidly Obese Kidney Transplants Under a Low Dose Valganciclovir Prophylaxis Protocol
    Thielke, J.
    West-Thielke, P.
    Benedetti, E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [6] Leucopenia in the First Year After Renal Transplantation During Valganciclovir Prophylaxis
    Rissling, O.
    Naik, M.
    Brakemeier, S.
    Schmidt, D.
    Hohberger, A.
    Neumayer, H.
    Budde, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 777 - 777
  • [7] Low-Dose Valganciclovir Prophylaxis Is Safe and Cost-Saving in CMV-Seropositive Kidney Transplant Recipients
    Shi, Yiyun
    Lerner, Alexis Hope
    Rogers, Ralph
    Vieira, Kendra
    Merhi, Basma
    Mecadon, Krista
    Osband, Adena J.
    Bayliss, George
    Gohh, Reginald
    Morrissey, Paul
    Farmakiotis, Dimitrios
    [J]. PROGRESS IN TRANSPLANTATION, 2021, 31 (04) : 368 - 376
  • [8] EXTENDED CMV PROPHYLAXIS WITH VALGANCICLOVIR IN RENAL TRANSPLANTATION REDUCES THE INCIDENCE OF CMV DISEASE
    Livesey, S.
    Walker, R.
    Toussaint, N.
    Crosthwaite, A.
    Ryan, J.
    Cohney, S.
    [J]. NEPHROLOGY, 2011, 16 : 79 - 79
  • [9] Risk Factors for the Development of CMV Viremia in a Cohort of Morbidly Obese Kidney Transplant Recipients Under Low Dose Valganciclovir Prophylaxis
    Thielke, J.
    Jasiak, N.
    Hilal, N.
    Salah, S.
    Benedetti, E.
    West-Thielke, P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 692 - 693
  • [10] Leucopenia in the First Year After Renal Transplantation During Valganciclovir Prophylaxis.
    Rissling, O.
    Naik, M.
    Brakemeier, S.
    Schmidt, D.
    Hohberger, A.
    Neumayer, H.
    Budde, K.
    [J]. TRANSPLANTATION, 2014, 98 : 777 - 777
12345